Basic Information

Symbol
circGCN1L1
RNA Class
circRNA
Alias
GCN1 Activator Of EIF2AK4 KIAA0219 GCN1L1 GCN1L GCN1 (General Control Of Amino-Acid Synthesis 1, Yeast)-Like 1 General Control Of Amino-Acid Synthesis 1-Like Protein 1 GCN1, EIF2 Alpha Kinase Activator Homolog GCN1 EIF-2-Alpha Kinase Activator Homolog Stalled Ribosome Sensor GCN1 Translational Activator GCN1 GCN1-Like Protein 1 HsGCN1 Peroxisome Proliferator Activated Receptor Interacting Complex Protein GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 (Yeast) GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 EIF-2-Alpha Kinase Activator GCN1 PRIC295
Location (GRCh37)
12:120567080-120632513 UCSC Genome Browser
Location (GRCh38)
Host gene
GCN1L1
Host category
mRNA
Forensic tag(s)
Other applications
External database

Transcripts

ID Type Location (GRCh37) Location (GRCh38) Length GC content
hsa_GCN1L1_0012900 Exon-Exon chr12:120593396-120606104 chr12:120155592-120168300 1921 nt 0.5825
hsa_GCN1L1_0013400 Exon-Exon chr12:120594716-120611973 chr12:120156912-120174169 2075 nt 0.5740
hsa_GCN1L1_0013500 Exon-Exon chr12:120594716-120632513 chr12:120156912-120194710 250 nt 0.4960
hsa_GCN1L1_0013600 Exon-Exon chr12:120596264-120596377 chr12:120158460-120158573 114 nt 0.6228
hsa_GCN1L1_0013700 Exon-Exon chr12:120596264-120602525 chr12:120158460-120164721 1293 nt 0.5800
hsa_GCN1L1_0013800 Exon-Exon chr12:120596264-120608125 chr12:120158460-120170321 1539 nt 0.5712
hsa_GCN1L1_0014000 Exon-Exon chr12:120597629-120602525 chr12:120159825-120164721 1137 nt 0.5734
hsa_GCN1L1_0014900 Exon-Exon chr12:120599684-120611630 chr12:120161880-120173826 1150 nt 0.5565
hsa_GCN1L1_0015100 Exon-Exon chr12:120600651-120600775 chr12:120162847-120162971 125 nt 0.5280
hsa_GCN1L1_0015200 Exon-Exon chr12:120600651-120601063 chr12:120162847-120163259 315 nt 0.5651
Showing 101 to 110 of 152 entries
Forensic Context

A review consolidating existing research indicates that in various mammalian species, the circGCN1L1 serves as an example where its expression was experimentally abolished using CRISPR/Cas9 genome-editing without affecting the expression of its corresponding linear mRNA [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].